Clinical Trial Update: MRD in High-risk EBC

View source ↗

Summary

An update on a clinical trial evaluating minimal residual disease in high-risk early breast cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Breast Cancer | Status: ACTIVE_NOT_RECRUITING